Comité del programa
-
Yasunari Kanda, PhD Head of Division of Pharmacology
National Institute of Health Sciences, Japan -
Keita Fujikawa Head of General Medicine, Japan Medical Office
Takeda Pharmaceutical Company Limited, Japan -
Yuji Kumagai, MD, PhD Professor, Kitasato Clinical Research Center
Kitasato University Hospital, Japan -
Atsushi Sugiyama, MD, PhD Professor and Chairman, Department of Pharmacology
Toho University Faculty of Medicine, Japan -
Kyosuke Takeshita, MD, PhD Department of Clinical Laboratory Medicine
Saitama Medical Center, Saitama Medical University, Japan -
Satoshi Tsunoda Specialist, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takashi Yoshinaga Executive Director, Advanced Biosignal Safety Assessment
Eisai Co., Ltd., Japan -
Kaori Shinagawa, MD, PhD Senior Scientist for Clinical Medicine, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
¿Tiene una cuenta?